---
title: "《大行》大摩降極兔速遞目標價至 9.1 元 維持「與大市同步」評級"
description: "大摩發表報告指，極兔速遞上半年業績因中國市場競爭加劇而未達預期，但東南亞及新興市場的增長前景似乎未受影響。該行將極兔速遞 2025 至 2027 年經調整淨利潤預測分別下調 17%、8% 及 16%，目標價由 9.5 元下調至 9.1 元，維持「與大市同步」評級，因估值處於合理水平。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/255411307.md"
published_at: "2025-09-01T06:37:09.000Z"
---

# 《大行》大摩降極兔速遞目標價至 9.1 元 維持「與大市同步」評級

> 大摩發表報告指，極兔速遞上半年業績因中國市場競爭加劇而未達預期，但東南亞及新興市場的增長前景似乎未受影響。該行將極兔速遞 2025 至 2027 年經調整淨利潤預測分別下調 17%、8% 及 16%，目標價由 9.5 元下調至 9.1 元，維持「與大市同步」評級，因估值處於合理水平。

大摩發表報告指，極兔速遞 (01519.HK) 上半年業績因中國市場競爭加劇而未達預期，但東南亞及新興市場的增長前景似乎未受影響。

該行將極兔速遞 2025 至 2027 年經調整淨利潤預測分別下調 17%、8% 及 16%，目標價由 9.5 元下調至 9.1 元，維持「與大市同步」評級，因估值處於合理水平。

### Related Stocks

- [01519.HK - 極兔速遞-W](https://longbridge.com/zh-HK/quote/01519.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| HK-listed J&T Global Express aims to raise $596 million for tech, overseas expansion | J&T Global Express, an Indonesian courier firm, aims to raise approximately HK$4.65 billion ($596 million) through conve | [Link](https://longbridge.com/zh-HK/news/273455551.md) |
| J&T Global Express to Raise HK$4.65 Billion via Premium-Priced Convertible Bonds | J&T Global Express Limited plans to raise HK$4.65 billion through a proposed issue of zero coupon guaranteed convertible | [Link](https://longbridge.com/zh-HK/news/273435757.md) |
| If SpaceX goes public in 2026, here’s what its stock price could realistically look like | If SpaceX goes public this year, the valuation could be absolutely staggering. But is this IPO just all hype, or is the  | [Link](https://longbridge.com/zh-HK/news/276424864.md) |
| BlackRock's long position in Li Ning increases to 5.33% on Feb 12, HKEX filing shows | BlackRock's long position in Li Ning increases to 5.33% on Feb 12, HKEX filing shows | [Link](https://longbridge.com/zh-HK/news/276432220.md) |
| Robosense Technology Forecasts Lower 2025 Losses | Robosense Technology Forecasts Lower 2025 Losses | [Link](https://longbridge.com/zh-HK/news/276402015.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。